Purple Biotech Ltd. — AGM Information 2016

Nov 2, 2016

Voting Slip – Part Two

Company name: Kitov Pharmaceuticals Holdings Limited, public company no. 520031238

Company address (for submission and delivery of Voting Slips): One Azieli Center, Round Tower, 23ª Floor, 132 New 6701101, Israel

Meeting date: Monday, December 5, 2016, at 4:30 p.m. (Israel Time).

Date of adjourned meeting: Monday, December 12, 2016, at 4:30 p.m. (Israel Time).

Meeting type: Annual General Meeting (the "Meeting").

Shareholder Details:

Shareholder Name:
Israeli ID no .:
For shareholders who are not in possession of an Israeli ID card:
Passport no .: ______________________________
Country of Issue:
Valid Until: ______________________________
For shareholders that are corporations:
Corporation no. : ________________________
Country of Incorporation:
Is the Shareholder any of the following 1:
A "Principal Shareholder"111: A "Senior Officer of the Company"21:

Yes / No
Yes / No
Yes / No

Manner of Voting:

Matter	Manner of voting
	For	Against	Abstain
Proposal 3.A To approve the Letter of Exemption granted by the Company to the director so named, which is in the form of such letter previously approved by the shareholders to be granted by the Company to directors serving from time to time in such capacity, a form of which is attached as Exhibit 10.5 to the Registration Statement on Form F-1 of the Company filed with the SEC on September 24, 2015.
ldo Agmon
i) Steven Steinberg
iii) Leah Bruck

1

l

3

4 . As defined in Regulation of Financial Services Regulations (Provident Funds)(Paticipation of a Management Company at a General Meeting), 5769-2009 as well as a Manager of Mutual Funds as per the meaning in the Mutual Funds Law, 5754-1999

II-1

Proposal 3.B To approve Letter of Indemnity granted by the Company to the director so named, which is in the form of such letter previously approved by the shareholders to be granted by the Company to directors serving from time to time in such capacity, a form of which is attached as Exhibit 10.6 to the Registration Statement on Form F-1 of the Company filed with the SEC on September 24, 2015.
Ido Agmon 1)
ii) Steven Steinberg
iii) Leah Bruck
Proposal 4 To approve the re-appointment of the applicable nominee for re-election as a director, to serve as a director of the Company in the first class of directors, commencing with the expiration of the applicable nominee's current term of office as a director, and to serve until the 2019 annual meeting of the Company, and until his successor has been duly appointed, at which time his term of office will end as set forth in the Company's Amended and Restated Articles of Association.
Proposal 4.A. Dr. Paul Waymack
Proposal 4.B. Dr. Alain Zeitoun

Mark X or V clearly in the appropriate column, in accordance with your voting decision.

Details:

Following are details in connection with my status as an interested in Section 1 of the Companies Law, for the proposed engagent:

Date

Signature

For shareholders holding shares through a stock exchange member (in accordance with Section 177(1) of the Companies Law, 5799 - 1999), this Voting Slip is only valid when accompanied by an certification of or shareholders registered in the Company's shareholder registry – this Voting Slip vill only be valid when accompanied by a photocopy of an ID / passport / certificate of incorporation.

II-2